These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 8157727

  • 1. Markers of bone turnover in hyperthyroidism and the effects of treatment.
    Garnero P, Vassy V, Bertholin A, Riou JP, Delmas PD.
    J Clin Endocrinol Metab; 1994 Apr; 78(4):955-9. PubMed ID: 8157727
    [Abstract] [Full Text] [Related]

  • 2. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [Abstract] [Full Text] [Related]

  • 3. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H, Papapetrou PD.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [Abstract] [Full Text] [Related]

  • 4. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P, Gineyts E, Riou JP, Delmas PD.
    J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
    [Abstract] [Full Text] [Related]

  • 5. Bone remodelling markers and serum cytokines in patients with hyperthyroidism.
    Akalin A, Colak O, Alatas O, Efe B.
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):125-9. PubMed ID: 12100080
    [Abstract] [Full Text] [Related]

  • 6. Early changes in parameters of bone and mineral metabolism during therapy for hyper- and hypothyroidism.
    Sabuncu T, Aksoy N, Arikan E, Ugur B, Tasan E, Hatemi H.
    Endocr Res; 2001 Jul; 27(1-2):203-13. PubMed ID: 11428712
    [Abstract] [Full Text] [Related]

  • 7. Serum bone Gla protein: a marker of bone turnover in hyperthyroidism.
    Garrel DR, Delmas PD, Malaval L, Tourniaire J.
    J Clin Endocrinol Metab; 1986 May; 62(5):1052-5. PubMed ID: 3485649
    [Abstract] [Full Text] [Related]

  • 8. Evidence of impaired cartilage/bone turnover in patients with active ankylosing spondylitis.
    Marhoffer W, Stracke H, Masoud I, Scheja M, Graef V, Bolten W, Federlin K.
    Ann Rheum Dis; 1995 Jul; 54(7):556-9. PubMed ID: 7668898
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 11. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers.
    Harvey RD, McHardy KC, Reid IW, Paterson F, Bewsher PD, Duncan A, Robins SP.
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1189-94. PubMed ID: 2026741
    [Abstract] [Full Text] [Related]

  • 12. Bone turnover in hyperthyroidism before and after thyrostatic management.
    Isaia GC, Roggia C, Gola D, Stefano MD, Gallone G, Aimo G, Ardissone P, Mussetta M.
    J Endocrinol Invest; 2000 Dec; 23(11):727-31. PubMed ID: 11194705
    [Abstract] [Full Text] [Related]

  • 13. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis.
    Delmas PD, Schlemmer A, Gineyts E, Riis B, Christiansen C.
    J Bone Miner Res; 1991 Jun; 6(6):639-44. PubMed ID: 1887826
    [Abstract] [Full Text] [Related]

  • 14. [Changes of bone and mineral metabolism in patients with hyperthyroidism before and after treatment].
    Chai R, Ye Z, Zhan Z.
    Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):682-4. PubMed ID: 11038794
    [Abstract] [Full Text] [Related]

  • 15. Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia.
    Body JJ, Delmas PD.
    J Clin Endocrinol Metab; 1992 Mar; 74(3):471-5. PubMed ID: 1740478
    [Abstract] [Full Text] [Related]

  • 16. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL, Loft AG, Møller N, Weeke J, Eriksen EF, Mosekilde L, Charles P.
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [Abstract] [Full Text] [Related]

  • 17. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
    Mitra D, Elvins DM, Collins AJ.
    J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
    [Abstract] [Full Text] [Related]

  • 18. [Monitoring markers of bone turnover in multiple myeloma].
    Spicka I, Spacek P, Hulejová H, Procházka B, Cieslar P, Chrz M, Válková V, Klener P.
    Vnitr Lek; 1999 Aug; 45(8):463-7. PubMed ID: 11045145
    [Abstract] [Full Text] [Related]

  • 19. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
    [Abstract] [Full Text] [Related]

  • 20. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
    Leder BZ, Smith MR, Fallon MA, Lee ML, Finkelstein JS.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):511-6. PubMed ID: 11158001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.